The Inclusion of Women in Global Oncology Drug Trials Over the Past 20 Years-Reference-Cited by-同舟云学术

The Inclusion of Women in Global Oncology Drug Trials Over the Past 20 Years

Published:2021-10-01 Issue:10 Volume:7 Page:1569
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Jenei Kristina¹,Meyers Daniel E.²,Prasad Vinay³

Affiliation:

1. School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada

2. Department of Medicine, University of Calgary, Calgary, Alberta, Canada

3. Department of Epidemiology and Biostatistics, University of California, San Francisco

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2783533/jamaoncology_jenei_2021_ld_210010_1634002340.00312.pdf

Reference6 articles.

1. Twenty years and still counting: including women as participants and studying sex and gender in biomedical research.;Mazure;BMC Womens Health,2015

2. Participation in cancer clinical trials: race-, sex-, and age-based disparities.;Murthy;JAMA,2004

3. Representation of minorities and women in oncology clinical trials: review of the past 14 years.;Duma;J Oncol Pract,2018

4. NIH Revitalization Act of 1993 Public Law 103-43. In: Mastroianni AC, Faden R, Federman D, eds. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies: Volume I. National Academies Press; 1994:appendix B. Accessed May 5, 2021. https://www.ncbi.nlm.nih.gov/books/NBK236531/

5. National Institutes of Health Office of Research on Women’s Health. Strategic plan. moving into the future with new dimensions and strategies: a vision for 2020 for women’s health research. Accessed July 22, 2021. https://orwh.od.nih.gov/sites/orwh/files/docs/ORWH_StrategicPlan2020_Vol1.pdf

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex as a Biological Variable in Early-Phase Oncology Clinical Trials: Enhancing the Path to Personalised Medicine;Heliyon;2024-06

2. Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease;Trends in Molecular Medicine;2024-06

3. In pursuit of parity: addressing gender disparities in global cancer research;BMJ Oncology;2024-04

4. Removing barriers to address sex differences in anticancer drug toxicity;Nature Reviews Cancer;2023-12-06

5. Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments;Value in Health;2023-09